The Female Athlete Triad

Sports Health

Volumn 4, Issue 4, 2012, Pages 302-311

  Nazem, Taraneh Gharib ^a   Ackerman, Kathryn E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

amenorrhea; bone mineral density; disordered eating; female athlete triad

Indexed keywords

EID: 84863315049     PISSN: 19417381     EISSN: 19410921     Source Type: Journal    
DOI: 10.1177/1941738112439685     Document Type: Article

References (133)

1. Abraham SF,Beumont PJ,Fraser IS,Llewellyn-Jones D.Body weight, exercise and menstrual status among ballet dancers in training.Br J Obstet Gynaecol. 1982;89 (7): 507-510.
2. Ackerman KE,Nazem T,Chapko D, et al.Bone microarchitecture is impaired in adolescent amenorrheic athletes compared with eumenorrheic athletes and nonathletic controls.J Clin Endocrinol Metab. 2011;96 (10): 3123-3133.
3. Hormonal contraception. ACOG technical bulletin. Number 198-October 1994 (replaces No. 106, July 1987).Int J Gynaecol Obstet. 1995;48 (1): 115-126.
4. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.Washington, DC: American Psychiatric Association; 2000.Washington, DC: American Psychiatric Association; 2000:.
5. Current evaluation of amenorrhea.Fertil Steril. 2008;90 (5): S219-S225.
6. Arcelus J,Mitchell AJ,Wales J,Nielsen S.Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies.Arch Gen Psychiatry. 2011;68 (7): 724-731.
7. Azziz R,Carmina E,Dewailly D, et al.The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.Fertil Steril. 2009;91 (2): 456-488.
8. Bachmann GA,Kemmann E.Prevalence of oligomenorrhea and amenorrhea in a college population.Am J Obstet Gynecol. 1982;144 (1): 98-102.
9. Bachrach LK.Consensus and controversy regarding osteoporosis in the pediatric population.Endocr Pract. 2007;13 (5): 513-520.
10. Bachrach LK.Measuring bone mass in children: can we really do it?.Horm Res. 2006;65:11-16.
11. Barrack MT,Rauh MJ,Barkai HS,Nichols JF.Dietary restraint and low bone mass in female adolescent endurance runners.Am J Clin Nutr. 2008;87 (1): 36-43.
12. Barrack MT,Van Loan MD,Rauh MJ,Nichols JF.Body mass, training, menses, and bone in adolescent runners: a 3-yr follow-up.Med Sci Sports Exerc. 2011;43 (6): 959-966.
13. Barrow GW,Saha S.Menstrual irregularity and stress fractures in collegiate female distance runners.Am J Sports Med. 1988;16 (3): 209-216.
14. Beals KADisordered Eating Among Athletes: A Comprehensive Guide for Health Professionals. Champaign, IL: Human Kinetics; 2004:.
15. Beals KA,Meyer NL.Female athlete triad update.Clin Sports Med. 2007;26 (1): 69-89.
16. Becker AE,Grinspoon SK,Klibanski A,Herzog DB.Eating disorders.N Engl J Med. 1999;340 (14): 1092-1098.
17. Bennell K,Matheson G,Meeuwisse W,Brukner P.Risk factors for stress fractures.Sports Med. 1999;28 (2): 91-122.
18. Bennell KL,Malcolm SA,Thomas SA, et al.Risk factors for stress fractures in track and field athletes: a twelve-month prospective study.Am J Sports Med. 1996;24 (6): 810-818.
19. Bennell KL,Malcolm SA,Thomas SA,Wark JD,Brukner PD.The incidence and distribution of stress fractures in competitive track and field athletes: a twelve-month prospective study.Am J Sports Med. 1996;24 (2): 211-217.
20. Bennell KL,Malcolm SA,Wark JD,Brukner PD.Skeletal effects of menstrual disturbances in athletes.Scand J Med Sci Sports. 1997;7 (5): 261-273.
21. Berga SL,Mortola JF,Girton L, et al.Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.J Clin Endocrinol Metab. 1989;68 (2): 301-308.
22. Blundell JE,King NA.Effects of exercise on appetite control: loose coupling between energy expenditure and energy intake.Int J Obes Relat Metab Disord. 1998;22:S22-S29.
23. Brunet ME,Cook SD,Brinker MR,Dickinson JA.A survey of running injuries in 1505 competitive and recreational runners.J Sports Med Phys Fitness. 1990;30 (3): 307-315.
24. Burrows M,Liu D,McKay H.High-resolution peripheral QCT imaging of bone micro-structure in adolescents.Osteoporos Int. 2010;21 (3): 515-520.
25. Byrne S,McLean N.Elite athletes: effects of the pressure to be thin.J Sci Med Sport. 2002;5 (2): 80-94.
26. Castelo-Branco C,Vicente JJ,Pons F, et al.Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.J Reprod Med. 2001;46 (10): 875-879.
27. Chou SH,Chamberland JP,Liu X, et al.Leptin is an effective treatment for hypothalamic amenorrhea.Proc Natl Acad Sci U S A. 2011;108 (16): 6585-6590.
28. Christo K,Cord J,Mendes N, et al.Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study.Clin Endocrinol (Oxf). 2008;69 (4): 628-633.
29. Cohen A.Should bisphosphonates be used in premenopausal women?.Maturitas. 2010;66 (1): 3-4.
30. Constantini NW,Arieli R,Chodick G,Dubnov-Raz G.High prevalence of vitamin D insufficiency in athletes and dancers.Clin J Sport Med. 2010;20 (5): 368-371.
31. Cumming DC.Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.Arch Intern Med. 1996;156 (19): 2193-2195.
32. Dale E,Gerlach DH,Wilhite AL.Menstrual dysfunction in distance runners.Obstet Gynecol. 1979;54 (1): 47-53.
33. De Souza MJ,Williams NI.Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women.Hum Reprod Update. 2004;10 (5): 433-448.
34. Drinkwater BL,Bruemner B,Chesnut CH.Menstrual history as a determinant of current bone density in young athletes.JAMA. 1990;263 (4): 545-548.
35. Drinkwater BL,Nilson K,Chesnut CH,Bremner WJ,Shainholtz S,Southworth MB.Bone mineral content of amenorrheic and eumenorrheic athletes.N Engl J Med. 1984;311 (5): 277-281.
36. Drinkwater BL,Nilson K,Ott S,Chesnut CH.Bone mineral density after resumption of menses in amenorrheic athletes.JAMA. 1986;256 (3): 380-382.
37. Dusek T.Influence of high intensity training on menstrual cycle disorders in athletes.Croat Med J. 2001;42 (1): 79-82.
38. Ettinger B,Ensrud KE,Wallace R, et al.Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.Obstet Gynecol. 2004;104 (3): 443-451.
39. Fogelman I,Ribot C,Smith R,Ethgen D,Sod E,Reginster JY.Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.J Clin Endocrinol Metab. 2000;85 (5): 1895-1900.
40. Forwood MR,Baxter-Jones AD,Beck TJ,Mirwald RL,Howard A,Bailey DA.Physical activity and strength of the femoral neck during the adolescent growth spurt: a longitudinal analysis.Bone. 2006;38 (4): 576-583.
41. Fredericson M,Kent K.Normalization of bone density in a previously amenorrheic runner with osteoporosis.Med Sci Sports Exerc. 2005;37 (9): 1481-1486.
42. Gibson JH,Mitchell A,Reeve J,Harries MG.Treatment of reduced bone mineral density in athletic amenorrhea: a pilot study.Osteoporos Int. 1999;10 (4): 284-289.
43. Gilsanz V,Chalfant J,Kalkwarf H, et al.Age at onset of puberty predicts bone mass in young adulthood.J Pediatr. 2011;158 (1): 100-105.
44. Gilsanz V,Chalfant J,Kalkwarf H, et al.Age at onset of puberty predicts bone mass in young adulthood [published online ahead of print August 24, 2010].J Pediatr.
45. Gilsanz V,Wren TA,Sanchez M,Dorey F,Judex S,Rubin C.Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD.J Bone Miner Res. 2006;21 (9): 1464-1474.
46. Golden NH,Iglesias EA,Jacobson MS, et al.Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial.J Clin Endocrinol Metab. 2005;90 (6): 3179-3185.
47. Golden NH,Lanzkowsky L,Schebendach J,Palestro CJ,Jacobson MS,Shenker IR.The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa.J Pediatr Adolesc Gynecol. 2002;15 (3): 135-143.
48. Gordon CM.Clinical practice: functional hypothalamic amenorrhea.N Engl J Med. 2010;363 (4): 365-371.
49. Gordon CM,Bachrach LK,Carpenter TO, et al.Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions.J Clin Densitom. 2008;11 (1): 43-58.
50. Gordon CM,DePeter KC,Feldman HA,Grace E,Emans SJ.Prevalence of vitamin D deficiency among healthy adolescents.Arch Pediatr Adolesc Med. 2004;158 (6): 531-537.
51. Gracia-Marco L,Vicente-Rodriguez G,Casajus JA,Molnar D,Castillo MJ,Moreno LA.Effect of fitness and physical activity on bone mass in adolescents: the HELENA Study [published online ahead of print March 11 2011].Eur J Appl Physiol.
52. Gulekli B,Davies MC,Jacobs HS.Effect of treatment on established osteoporosis in young women with amenorrhoea.Clin Endocrinol (Oxf). 1994;41 (3): 275-281.
53. Haenggi W,Casez JP,Birkhaeuser MH,Lippuner K,Jaeger P.Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel.Osteoporos Int. 1994;4 (2): 99-103.
54. Hans D,Downs RW,Duboeuf F, et al.Skeletal sites for osteoporosis diagnosis: the 2005 ISCD Official Positions.J Clin Densitom. 2006;9 (1): 15-21.
55. Harber VJ,Petersen SR,Chilibeck PD.Thyroid hormone concentrations and muscle metabolism in amenorrheic and eumenorrheic athletes.Can J Appl Physiol. 1998;23 (3): 293-306.
56. Harel Z,Gold M,Cromer B, et al.Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.J Adolesc Health. 2007;40 (1): 44-53.
57. Hergenroeder AC,Smith EO,Shypailo R,Jones LA,Klish WJ,Ellis K.Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.Am J Obstet Gynecol. 1997;176 (5): 1017-1025.
58. Hull MG,Knuth UA,Murray MA,Jacobs HS.The practical value of the progestogen challenge test, serum oestradiol estimation or clinical examination in assessment of the oestrogen state and response to clomiphene in amenorrhoea.Br J Obstet Gynaecol. 1979;86 (10): 799-805.
59. International Society for Clinical Densitometry. Updated 2005 official positions for the international society for clinical densitometry. http://www.iscd.org/Visitors/positions/OfficialPositionsText.cfm. Accessed May 1, 2011.
60. Iwamoto J,Takeda T.Stress fractures in athletes: review of 196 cases.J Orthop Sci. 2003;8 (3): 273-278.
61. Kam GY,Leung KC,Baxter RC,Ho KK.Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.J Clin Endocrinol Metab. 2000;85 (5): 1918-1922.
62. Kanis JA,McCloskey EV,Johansson H,Oden A,Melton LJ,Khaltaev N.A reference standard for the description of osteoporosis.Bone. 2008;42 (3): 467-475.
63. Kawai M,Modder UI,Khosla S,Rosen CJ.Emerging therapeutic opportunities for skeletal restoration.Nat Rev Drug Discov. 2011;10 (2): 141-156.
64. Keen AD,Drinkwater BL.Irreversible bone loss in former amenorrheic athletes.Osteoporos Int. 1997;7 (4): 311-315.
65. Khan AA,Bachrach L,Brown JP, et al.Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children.J Clin Densitom. 2004;7 (1): 51-64.
66. Khan AA,Hanley DA,Bilezikian JP, et al.Standards for performing DXA in individuals with secondary causes of osteoporosis.J Clin Densitom. 2006;9 (1): 47-57.
67. Khan KM,Liu-Ambrose T,Sran MM,Ashe MC,Donaldson MG,Wark JD.New criteria for female athlete triad syndrome? As osteoporosis is rare, should osteopenia be among the criteria for defining the female athlete triad syndrome?.Br J Sports Med. 2002;36 (1): 10-13.
68. Kreipe RE,Forbes GB.Osteoporosis: a "new morbidity" for dieting female adolescents?.Pediatrics. 1990;86 (3): 478-480.
69. Lattakova M,Borovsky M,Payer J,Killinger Z.Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls.Eur J Contracept Reprod Health Care. 2009;14 (3): 207-214.
70. Lauder TD,Dixit S,Pezzin LE,Williams MV,Campbell CS,Davis GD.The relation between stress fractures and bone mineral density: evidence from active-duty army women.Arch Phys Med Rehabil. 2000;81 (1): 73-79.
71. Lewandowski KC,Cajdler-Luba A,Salata I,Bienkiewicz M,Lewinski A.The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).Endokrynol Pol. 2011;62 (2): 120-128.
72. Lieberman EH,Gerhard MD,Uehata A, et al.Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women.Ann Intern Med. 1994;121 (12): 936-941.
73. Lilenfeld LR,Kaye WH,Greeno CG, et al.A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity.Arch Gen Psychiatry. 1998;55 (7): 603-610.
74. Lindberg JS,Powell MR,Hunt MM,Ducey DE,Wade CE.Increased vertebral bone mineral in response to reduced exercise in amenorrheic runners.West J Med. 1987;146 (1): 39-42.
75. Lirani-Galvao AP,Bergamaschi CT,Silva OL,Lazaretti-Castro M.Electrical field stimulation improves bone mineral density in ovariectomized rats.Braz J Med Biol Res. 2006;39 (11): 1501-1505.
76. Lloyd T,Triantafyllou SJ,Baker ER, et al.Women athletes with menstrual irregularity have increased musculoskeletal injuries.Med Sci Sports Exerc. 1986;18 (4): 374-379.
77. Lobo RA,Paul WL,Goebelsmann U.Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.Obstet Gynecol. 1981;57 (1): 69-73.
78. Loucks AB.Energy balance and body composition in sports and exercise.J Sports Sci. 2004;22 (1): 1-14.
79. Loucks AB,Horvath SM.Athletic amenorrhea: a review.Med Sci Sports Exerc. 1985;17 (1): 56-72.
80. Loucks AB,Mortola JF,Girton L,Yen SS.Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women.J Clin Endocrinol Metab. 1989;68 (2): 402-411.
81. Loucks AB,Thuma JR.Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women.J Clin Endocrinol Metab. 2003;88 (1): 297-311.
82. Manore MM.Dietary recommendations and athletic menstrual dysfunction.Sports Med. 2002;32 (14): 887-901.
83. Manore MM,Kam LC,Loucks AB.The female athlete triad: components, nutrition issues, and health consequences.J Sports Sci. 2007;25:S61-S71.
84. McKay H,Liu D,Egeli D,Boyd S,Burrows M.Physical activity positively predicts bone architecture and bone strength in adolescent males and females [published online ahead of print September 14, 2010].Acta Paediatr.
85. Meczekalski B,Podfigurna-Stopa A,Genazzani AR.Hypoestrogenism in young women and its influence on bone mass density.Gynecol Endocrinol. 2010;26 (9): 652-657.
86. Meczekalski B,Podfigurna-Stopa A,Warenik-Szymankiewicz A,Genazzani AR.Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations.Gynecol Endocrinol. 2008;24 (1): 4-11.
87. Current evaluation of amenorrhea.Fertil Steril. 2004;82:S33-S39.
88. Miller KK,Grieco KA,Mulder J, et al.Effects of risedronate on bone density in anorexia nervosa.J Clin Endocrinol Metab. 2004;89 (8): 3903-3906.
89. Misra M,Klibanski A.Anorexia nervosa and osteoporosis.Rev Endocr Metab Disord. 2006;7:91-99.
90. Montero A,Lopez-Varela S,Nova E,Marcos A.The implication of the binomial nutrition-immunity on sportswomen's health.Eur J Clin Nutr. 2002;56:S38-S41.
91. Myburgh KH,Hutchins J,Fataar AB,Hough SF,Noakes TD.Low bone density is an etiologic factor for stress fractures in athletes.Ann Intern Med. 1990;113 (10): 754-759.
92. Nattiv A,Agostini R,Drinkwater B,Yeager KK.The female athlete triad: the inter-relatedness of disordered eating, amenorrhea, and osteoporosis.Clin Sports Med. 1994;13 (2): 405-418.
93. Nattiv A,Loucks AB,Manore MM,Sanborn CF,Sundgot-Borgen J,Warren MP.American College of Sports Medicine position stand: the female athlete triad.Med Sci Sports Exerc. 2007;39 (10): 1867-1882.
94. Nehlsen-Cannarella SL.Cellular responses to moderate and heavy exercise.Can J Physiol Pharmacol. 1998;76 (5): 485-489.
95. Nichols DL,Sanborn CF,Essery EV.Bone density and young athletic women: an update.Sports Med. 2007;37 (11): 1001-1014.
96. Otis CL,Drinkwater B,Johnson M,Loucks A,Wilmore J.American College of Sports Medicine position stand: the female athlete triad.Med Sci Sports Exerc. 1997;29 (5).
97. Perregaux D,Chaudhuri A,Mohanty P, et al.Effect of gender differences and estrogen replacement therapy on vascular reactivity.Metabolism. 1999;48 (2): 227-232.
98. Incidence and prevalence rates.Am J Obstet Gynecol. 1973;117 (1): 80-86.
99. Rencken ML,Chesnut CH,Drinkwater BL.Bone density at multiple skeletal sites in amenorrheic athletes.JAMA. 1996;276 (3): 238-240.
100. Rickenlund A,Carlstrom K,Ekblom B,Brismar TB,Von Schoultz B,Hirschberg AL.Effects of oral contraceptives on body composition and physical performance in female athletes.J Clin Endocrinol Metab. 2004;89 (9): 4364-4370.
101. Rickenlund A,Eriksson MJ,Schenck-Gustafsson K,Hirschberg AL.Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile.J Clin Endocrinol Metab. 2005;90 (3): 1354-1359.
102. Riggs BL,Khosla S,Atkinson EJ,Dunstan CR,Melton LJ.Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency.Osteoporos Int. 2003;14 (9): 728-733.
103. Ross AC,Manson JE,Abrams SA, et al.The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.J Clin Endocrinol Metab. 2011;96 (1): 53-58.
104. Rubin C,Recker R,Cullen D,Ryaby J,McCabe J,McLeod K.Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.J Bone Miner Res. 2004;19 (3): 343-351.
105. Rubin CD.Emerging concepts in osteoporosis and bone strength.Curr Med Res Opin. 2005;21 (7): 1049-1056.
106. Russell M,Stark J,Nayak S, et al.Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls.Bone. 2009;45 (1): 104-109.
107. Samsioe G.Transdermal hormone therapy: gels and patches.Climacteric. 2004;7 (4): 347-356.
108. Sanborn CF,Horea M,Siemers BJ,Dieringer KI.Disordered eating and the female athlete triad.Clin Sports Med. 2000;19 (2): 199-213.
109. Sanborn CF,Martin BJ,Wagner WW.Is athletic amenorrhea specific to runners?.Am J Obstet Gynecol. 1982;143 (8): 859-861.
110. Scholes D,Ichikawa L,LaCroix AZ, et al.Oral contraceptive use and bone density in adolescent and young adult women.Contraception. 2010;81 (1): 35-40.
111. Schwartz B,Cumming DC,Riordan E,Selye M,Yen SS,Rebar RW.Exercise-associated amenorrhea: a distinct entity?.Am J Obstet Gynecol. 1981;141 (6): 662-670.
112. Shaffer RA,Rauh MJ,Brodine SK,Trone DW,Macera CA.Predictors of stress fracture susceptibility in young female recruits.Am J Sports Med. 2006;34 (1): 108-115.
113. Singh KB.Menstrual disorders in college students.Am J Obstet Gynecol. 1981;140 (3): 299-302.
114. Slatkovska L,Alibhai SM,Beyene J,Cheung AM.Effect of whole-body vibration on BMD: a systematic review and meta-analysis.Osteoporos Int. 2010;21 (12): 1969-1980.
115. Soyka LA,Fairfield WP,Klibanski A.Clinical review 117: Hormonal determinants and disorders of peak bone mass in children.J Clin Endocrinol Metab. 2000;85 (11): 3951-3963.
116. Sundgot-Borgen J.Risk and trigger factors for the development of eating disorders in female elite athletes.Med Sci Sports Exerc. 1994;26 (4): 414-419.
117. Sundgot-Borgen J.Weight and eating disorders in elite athletes.Scand J Med Sci Sports. 2002;12 (5): 259-260.
118. Sundgot-Borgen J,Torstveit MK.Aspects of disordered eating continuum in elite high-intensity sports.Scand J Med Sci Sports. 2010;20:112-121.
119. Sundgot-Borgen J,Torstveit MK.Prevalence of eating disorders in elite athletes is higher than in the general population.Clin J Sport Med. 2004;14 (1): 25-32.
120. Tabrah F,Hoffmeier M,Gilbert F,Batkin S,Bassett CA.Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs).J Bone Miner Res. 1990;5 (5): 437-442.
121. Tenforde AS,Fredericson M.Influence of sports participation on bone health in the young athlete: a review of the literature.PM R. 2011;3 (9): 861-867.
122. Theintz G,Buchs B,Rizzoli R, et al.Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.J Clin Endocrinol Metab. 1992;75 (4): 1060-1065.
123. Torstveit MK,Rosenvinge JH,Sundgot-Borgen J.Prevalence of eating disorders and the predictive power of risk models in female elite athletes: a controlled study.Scand J Med Sci Sports. 2008;18 (1): 108-118.
124. Torstveit MK,Sundgot-Borgen J.The female athlete triad exists in both elite athletes and controls.Med Sci Sports Exerc. 2005;37 (9): 1449-1459.
125. Veldhuis JD,Evans WS,Demers LM,Thorner MO,Wakat D,Rogol AD.Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.J Clin Endocrinol Metab. 1985;61 (3): 557-563.
126. Viswanathan V,Eugster EA.Etiology and treatment of hypogonadism in adolescents.Pediatr Clin North Am. 2011;58 (5): 1181-1200.
127. Walsh JM,Wheat ME,Freund K.Detection, evaluation, and treatment of eating disorders the role of the primary care physician.J Gen Intern Med. 2000;15 (8): 577-590.
128. Warming L,Ravn P,Christiansen C.Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.Maturitas. 2005;50 (2): 78-85.
129. Warren MP,Brooks-Gunn J,Fox RP,Holderness CC,Hyle EP,Hamilton WG.Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study.J Clin Endocrinol Metab. 2002;87 (7): 3162-3168.
130. Weissberger AJ,Ho KK,Lazarus L.Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.J Clin Endocrinol Metab. 1991;72 (2): 374-381.
131. Welt CK,Chan JL,Bullen J, et al.Recombinant human leptin in women with hypothalamic amenorrhea.N Engl J Med. 2004;351 (10): 987-997.
132. Willenberg HS,Bahlo M,Schott M,Wertenbruch T,Feldkamp J,Scherbaum WA.Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women.Steroids. 2008;73 (1): 41-46.
133. Yeager KK,Agostini R,Nattiv A,Drinkwater B.The female athlete triad: disordered eating, amenorrhea, osteoporosis.Med Sci Sports Exerc. 1993;25 (7): 775-777.